Sporos Bioventures takes in $38.1m Series A

Sporos Bioventures, a new biotech company, has secured $38.1 million in Series A financing.

Sporos Bioventures, a new biotech company, has secured $38.1 million in Series A financing. The investors included Dr. Ronald DePinho, Sporos Director Peter Feinberg and Chief Scientific Officer Dr. Jeno Gyuris.

Source: Press Release